GLP Watchdog

Hers vs HumeCare+

Hers has an open FDA warning letter dated September 9, 2025. HumeCare+ has none. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at HumeCare+.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / HumeCare+

Hers logo

Hers

6.8/10

Featured pick (affiliate partner)

HumeCare+ logo

HumeCare+

6.6/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states
46 states and DC
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit HersFull review
Visit HumeCare+Full review

HumeCare+ is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Hers 6.8, HumeCare+ 6.6). How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. HumeCare+ has none.

  2. 02

    Hers names three pharmacies. HumeCare+ names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at HumeCare+.

  4. 04

    Only Hers lists a price for brand-name tirzepatide pen. Only HumeCare+ lists a price for compounded tirzepatide injection and compounded oral semaglutide.

  5. 05

    Hers covers four states HumeCare+ does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

HumeCare+

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection
Not sold or not priced

$299/mo

$3,588 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$199/mo

$2,388 a year

Price includes
Medication
Medication, clinician visits, shipping
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None
Refunds
No refund guaranteed once the pharmacy has processed an order
Membership fee refunded if the clinician finds you ineligible (device returned); otherwise non-refundable, no pro-rated refunds
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Hers: September 28, 2026. HumeCare+: August 14, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which HumeCare+ does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for HumeCare+

6.6/10
Featured pick (affiliate partner)
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection and compounded oral semaglutide, which Hers does not price
  • Price includes clinician visits
  • Names no compounding pharmacy
Visit HumeCare+

Scores

Hers 6.8 · HumeCare+ 6.6 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.0A
vs
B
5.0

Accessibility10%

10.0A
vs
B
9.4

Support10%

3.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs HumeCare+: questions

Hers has an open FDA warning letter dated September 9, 2025. HumeCare+ has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. HumeCare+ names no compounding pharmacy in our record.
Neither, by more than $1 a month. Hers charges $199 a month and HumeCare+ $199 a month.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. HumeCare+ states you can cancel at any time; refunds: membership fee refunded if the clinician finds you ineligible (device returned); otherwise non-refundable, no pro-rated refunds.
HumeCare+ is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Hers 6.8, HumeCare+ 6.6).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks